Krishnaswamy Yeleswaram, Chief Development Officer at Rapport Therapeutics, sold RAPP on Aug 25, 2026
Data as of Oct 16
▼ SELL$827K16,201 shares at $51.06Krishnaswamy Yeleswaram Chief Development OfficerRAPP Rapport Therapeutics, Inc.
- Traded
- Aug 25, 2026
- Disclosed
- Aug 26, 2026
- Filed
- 1 day after the trade
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
RAPP since disclosure
−47.5%
after the sale
Similar stocks (SPY) since disclosure
−0.4%
S&P 500 (SPY)
Change in closing price from Aug 26, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.
Other trades in the same filing
- ▼ SELLKrishnaswamy Yeleswaram Chief Development OfficerRAPP Rapport Therapeutics, Inc.$1Mdisclosed Aug 26 · filed 1 day after the trade
- ▼ SELLKrishnaswamy Yeleswaram Chief Development OfficerRAPP Rapport Therapeutics, Inc.$658Kdisclosed Aug 26 · filed 2 days after the trade